Dec. 17 (Bloomberg) -- A clot-busting drug made by Boehringer Ingelheim GmbH didn’t improve the survival of patients who were treated away from a hospital after their hearts stopped functioning, a study found.
Dec. 17 (Bloomberg) -- A clot-busting drug made by Boehringer Ingelheim GmbH didn’t improve the survival of patients who were treated away from a hospital after their hearts stopped functioning, a study found.
